Lipid lowering versus revascularization: An idea whose time (for testing) has come

Circulation

Volumn 96, Issue 4, 1997, Pages 1360-1362

  Forrester, James S ^a   Shah, Prediman K ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Angina; Atherosclerosis; Lipids; Myocardial infarction

Indexed keywords

ANTILIPEMIC AGENT;

ANGIOCARDIOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; COST EFFECTIVENESS ANALYSIS; HEALTH CARE POLICY; HEALTH ECONOMICS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERLIPIDEMIA; PRIORITY JOURNAL; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0030843338     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.4.1360     Document Type: Review

References (34)

1. Muhlbaier L, Pryor D, Rankin J, Smith LR, Mark D, Jones R, Glower D, Harrell F Jr, Lee K, Califf R, Sabiston D Jr. Observational comparison of event-free survival with medical and surgical therapy in patients with coronary artery disease: 20 years of follow-up. Circulation. 1992;86(suppl II):II-198-II-204.
2. Davis KB, Alderman EL, Kosinski AS, Passamani E, Kennedy JW. Early mortality of acute myocardial infarction in patients with and without prior coronary revascularization surgery: a Coronary Artery Surgery Study Registry study. Circulation. 1992;85: 2100-2109.
3. Wiseman A, Waters D, Walling A, Pelletier G, Roy D, Theroux P. Long-term prognosis after myocardial infarction in patients with previous coronary artery bypass surgery. J Am Coll Cardiol. 1988; 12:873-880.
4. Mark D, Nelson C, Califf R, Harrell F, Lee K, Jones R, Fortin D, Stack R, Glower D, Smith L, DeLong E, Smith P, Reves J, Jollis J, Tceng J, Muhlbaier L, Lowe J, Phillips H, Pryor D. Continuing evolution of therapy for coronary artery disease: initial results from the era of coronary angioplasty. Circulation. 1994;89:2015-2025.
5. Mock ME. Survival of medically treated patients in the Coronary Artery Surgery (CASS) Registry. Circulation. 1982;66:562-568.
6. Nishiyama S, Iwase T, Ishiwata S, Komiyama N, Yanagishita Y, Nakanishi S, Seki A. Comparison of long-term efficacy of medical treatment versus percutaneous transluminal coronary angioplasty (PTCA) in single-vessel disease. Jpn Heart J. 1995;36:565-572.
7. Pocock S, Henderson R, Rickards A, Hampton J, King S, Hamm C, Fuel J, Hueb W, Goy J, Rodriguez A. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet. 1995;346:1184-1189.
8. Parisi A, Folland E, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med. 1992;326:10-16.
9. Moise A, Clement B, Saltiel J. Clinical and angiographic correlates and prognostic significance of the coronary extent score. Am J Cardiol. 1988;61:1255-1259.
10. Ambrose J, Tannenbaum M, Alexopoulos D, Hjemdahl-Monsen C, Leavy J, Weiss M, Borrico S, Gorlin R, Fuster V. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 1988;12:56-62.
11. Little W, Downes T, Applegate R. The underlying coronary lesion in myocardial infarction: implications for coronary angiography. Clin Cardiol. 1991;14:868-874.
12. Ellis S, Alderman E, Cain K, Fisher L, Sanders W, Bourassa M, CASS Investigators. Prediction of risk of anterior myocardial infarction by lesion severity and measurement method of stenoses in the left anterior descending coronary distribution. J Am Coll Cardiol. 1988;11:908-916.
13. Hacket D, Verwilghen J, Davies G, Maseri A. Coronary stenoses before and after acute myocardial infarction. Am J Cardiol. 1989; 63:1517-1518.
14. Webster M, Chesebro J, Smith H, Frye R, Holmes D, Reeder G, Bresnahan D, Nishimura R, Clements I, Bardsley W, Grill D, Bailey K, Fuster V. Myocardial infarction and coronary artery occlusion: a prospective 5-year angioaraphic study. J Am Coll Cardiol. 1990;15:218A. Abstract.
15. Kerensky R, Kutcher M, Mumma M, Applegate R, Little W. Myocardial infarction late after successful PTCA: progression of disease versus reoccurrence. J Am Coll Cardiol. 1991;17:304a. Abstract.
16. Little W, Gwinn N, Burrows M, Kutcher M, Kahl F, Applegate R. Cause of acute myocardial infarction late after successful coronary artery bypass graft. Am J Cardiol. 1990;65:808-810.
17. Brown BG, Gallery C, Badger R, Kennedy JW, Mather D, Bolson E, Dodge H. Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusions of streptokinase for acute myocardial infarction: quantitative angiographic observations. Circulation. 1986;73:653-661.
18. Alderman E, Corley S, Fisher L, Chaitman B, Faxon D, Foster E, Killip T, Sosa J, Bourassa M, CASS participating investigators and staff. Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). J Am Coll Cardiol. 1993;22:1141-1154.
19. Nobuyoshi M, Tanaka M, Nosaka H, Kimura T, Yokoi H, Hamasaki N, Kim K, Shindo T, Kimura K. Progression of coronary atherosclerosis: is coronary spasm related to progression? J Am Coll Cardiol. 1991;18:904-910.
20. Giroud D, Li J, Urban P, Meier B, Rutishauser W. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol. 1992;69: 729-732.
21. Waters D. Plaque stabilization: a mechanism for the beneficial effect of lipid-lowering therapies in angiography studies. Prog Cardiovasc Dis. 1994;37:107-120.
22. Falk E, Shah P, Fuster V. Coronary plaque disruption. Circulation 1995;92:657-671.
23. Davies M, Richardson P, Woolf N, Katz D, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 1993;69:377-381.
24. Gertz S, Roberts W. Hemodynamic shear force in rupture of coronary arterial atherosclerotic plaques. Am J Cardiol. 1990;66: 1368-1372.
25. van der Wal A, Becker A, van der Loos C, Das P. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
26. Forrester J, Litvack F, Grundfest W, Hickey A. A perspective of coronary disease seen through the arteries of living man. Circulation. 1987;75:505-513.
27. Mizuno K, Satomura K, Miyamoto A, Arakawa K, Shibuya T, Arai T, Kurita A, Nakamura H, Ambrose J. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N Engl J Med. 1992;326:287-291.
28. Danchin N. Is myocardial revascularisation for tight coronary stenoses always necessary? Lancet. 1993;342:224-225.
29. Pekkanen J, Linn S, Heiss G, Suchindran C, Leon A, Rifkind B, Tyroler H. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med. 1990;322:1700-1707.
30. Wong N, Wilson P, Kannel W. Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study. Ann Intern Med. 1991;115:687-693.
31. Sigurdsson E, Sigfusson N, Agnarsson U, Sigvaldason H, Thorgeirsson G. Long-term prognosis of different forms of coronary heart disease: the Reykjavik Study. Int J Epidemiol. 1995; 24:58-68.
32. Connelly P, MacLean D, Horlick L, O'Connor B, Petrasovits A, Little J. Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group. Can Med Assoc J. 1992;146: 1977-1987.
33. Anonymous. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
34. Shepherd J, Cobbe S, Ford I, Isles C, Lorimer A, MacFarlane P, McKillop J, Packard C. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333: 1301-1307.